Message from the Managing Director’s Desk

As we continue to navigate the ever-changing clinical research industry, I am pleased to share some perspectives and developments within our company that will drive our future growth strategies.

We have made a paradigm shift in our operations in the US and Canada, with consolidation of Lambda Therapeutic Research’s Toronto, Canada clinic and bioanalytical laboratory into Novum operations. Canada’s state-of-the-art facility offers niche Pharmacokinetics (PK), Late Phase and Complex Bioanalytical services, which we feel would be a comprehensive value-add in your Drug development programs. By embracing the Novum brand, with its nearly fifty year history, as across our North American operations, we will deliver an enhanced, more seamless suite of services to our clients.

Read More

​Turnkey Clinical Trial Management solution for YOUR drug development programs

Guided by a senior management team with expertise in science, operations, quality assurance, medical affairs and project management, Novum offers the highest levels of integrity and reliability.

Early Phase CRO

Nearly fifty years of high-quality research outcomes.

Novum is a full-service CRO with an impeccable performance record and numerous FDA approvals in new drug, 505(b)(2) and ANDA submissions. We manage complex studies across numerous therapeutic areas and dosage forms, spanning early phase to late phase trials. With the full integration of our bioanalytical unit in Toronto, Canada in 2020, Novum is poised to continue its longstanding tradition of serving clients with safety, quality, and scientific leadership.

Contact Us

Let’s Talk

There are plenty of ways to get in touch. Just select the one that is best for you.


Novum prides itself on its talented and dedicated team of employees. The Novum team is passionate about customer satisfaction, safety and study integrity. All Novum clinical staff members receive extensive training designed to continually hone and increase the skills of each employee.

clinical data management company

Want to participate in a study?

Last year we paid over $6.6 million to participants of our research studies.